Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Kassim Javaid has been announced as one the successful applicants of The Royal Osteoporosis Society’s largest ever research grants round.

Horizontal portrait of Kassim Javid

Half of women and one fifth of men will break a bone due to osteoporosis. The Royal Osteoporosis Society research grants programme aims to change that, by offering researchers at various stages in their careers the opportunity to apply for funding that will allow them to undertake pioneering research and improve our understanding of osteoporosis.

Dr Kassim Javaid, Associate Professor at NDORMS is one of the successful applicants for his research proposal into real world data audits to help identify high-risk fracture patient and the impacts on secondary fracture prevention.

Kassim said: "We were delighted to hear that the ROS has supported our research project. Our research will help patients, who have recently broken a bone after a fall, receive the best care possible to reduce their risk of another broken bone. Our team of researchers and patients will work to understand the ingredients that make fracture liaison services run well. We will also identify patients at higher risk of another hip fracture and may need to be fast-tracked to more stronger bone treatments."

Dr Caroline Sangan, Research Manager at the ROS, said: "We've been really impressed with the quality of applications we received as part of this year's research grants programme. Five project grants, one early career grant and one innovative grant have been chosen.

"Each application was reviewed by our Research Grants Assessment Panel before being peer reviewed, to ensure that we fund research of the highest standard that also meets our objectives as a charity. We were pleased to see this year's successful applicants included detailed plans on how they'd involve individuals with experience of osteoporosis in their research, with over 50% even including them as a co-applicant."

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8th October 2026.

Adam Croft appointed Norman Collisson Professor of Musculoskeletal Science

This appointment brings a further focus to linking rheumatology discovery science and clinical trials in NDORMS, strengthening translational rheumatology research across the department to deliver transformative treatments for patients with inflammatory arthritis.

NIHR fellowship to support national trial evaluating rehabilitation after kneecap dislocation

Dr Colin Forde has been awarded a National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Postdoctoral Award to lead a national study evaluating rehabilitation for people with a kneecap (patellar) dislocation.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Professor Afsie Sabokbar retires after more than 30 years at NDORMS

Botnar Institute Director of Graduate Studies, Professor Afsie Sabokbar, is retiring after more than 30 years at NDORMS.

Researchers funded to cure – rather than manage – inflammatory disease

Researchers from the Kennedy Institute of Rheumatology will join international partners in a bid to transform how chronic inflammatory disease is treated.